English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A R T I C L E I N F O A B S T R A C T Article history: Received: 05 September, 2018 Revised: 30 September, 2018 Accepted: 14 November, 2018 Cervical cancer is the 4th most common cancer in women in low to middle income group countries (LMIC). Various methods for screening cervical cancer are practiced, such as the Conventional Pap Smear (CPS), Liquid Based Cytology with its ancillary techniques like Cell Block with immunocytochemistry. VIA is another method which is being advocated as a primary screening tool. Molecular diagnostics such as use of HPV DNA testing has been at the forefront of the screening programs. In the present study, we have utilized all the above methods by using cost effective in-house procedures to explore their possible utility in the clinical settings. We found them useful with need for more work and training of personnel for better diagnosis of cervical cancer.

advances in science, technology and engineering systems journal

Exploring the use of Manual Liquid Based Cytology, Cell Block with Immunomarkers p16/ki67, VIA and HPV DNA Testing as a Strategy for Cervical Cancer Screening in LMIC